Company: BLLN
Filing Date: 2025-12-10
Form Type: 10-Q
Source: 0001628280-25-056321
Chunk: 491

Company: BillionToOne, Inc.
Filing Date: 2025-12-10
Form: 10-Q
Item: Part I, Item 8
Chunk 491
---
. The offering terminated after the sale of all securities registered pursuant to the Registration Statement. J.P. Morgan Securities LLC, 

94

Piper Sandler & Co., Jefferies LLC, William Blair & Company, L.L.C., Stifel, Nicolaus & Company, Incorporated, Wells Fargo Securities, LLC, and BTIG, LLC acted as representatives of the underwriters for the IPO. 

There has been no material change in the expected use of the net proceeds from our IPO as described in the final prospectus dated as of November 5, 2025 and filed with the SEC pursuant to Rule 424(b)(4) on November 6, 2025.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

Disclosure of Trading Arrangements

During the fiscal quarter ended September 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K. 

Item 6. Exhibits 

(a) Exhibits

Exhibit NoDescription of ExhibitFormFile No.Exhibit NumberFiling DateFiled or Furnished Herewith3.1Amended and Restated Certificate of Incorporation of the Registrant8-K001-429343.1November 10, 20253.2Amended and Restated Bylaws of Registrant8-K001-429343.2November 10, 202510.1Amendment No. 1 to the Note Purchase Agreement, dated as September 4, 2025, by and among by and among the Registrant, the purchasers party thereto, and BWCB SA LLC (an entity affiliated with Oberland Capital Management, LLC), as purchaser’s agent.S-1333-29076110.2October 07, 202510.2Development and Commercialization Agreement with Janssen Biotech, Inc., dated July 11, 2025S-1/A333-29076110.10October 17, 202510.3Amendment No. 1 to Development and Commercialization Agreement with Janssen Biotech, Inc., dated October 15, 2025S-1/A333-29076110.11October